Swallowing outcomes for patients with oropharyngeal squamous cell carcinoma treated with primary (chemo)radiation therapy receiving either prophylactic gastrostomy or reactive nasogastric tube: A prospective cohort study.
Diane GoffS CowardA FitzgeraldVinidh PaleriJames W MoorJ M PattersonPublished in: Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery (2017)
There is no statistical difference for swallowing outcomes in either group. However, patients' in the rNGT group reported a clinically meaningful difference at 1 year, with a trend for them to do better across all measures. Neither group returned to their baseline swallowing function. Further research with a larger sample size is indicated.
Keyphrases
- squamous cell carcinoma
- radiation therapy
- newly diagnosed
- end stage renal disease
- ejection fraction
- chronic kidney disease
- locally advanced
- prognostic factors
- photodynamic therapy
- patient reported outcomes
- lymph node metastasis
- drug delivery
- radiation induced
- skeletal muscle
- combination therapy
- metabolic syndrome
- patient reported
- glycemic control